Navigation Links
Islet Cell Transplants Aid Type 1 Diabetics
Date:5/16/2008

ry exciting, and it's very important, but this study doesn't provide a lot of new information.

"Islet cell transplantation works, and it works very well for about a year, but the complications of the agents used to prevent rejection are still there. And, they're also causing a decrease in the survival of the new beta cells," he added.

More information

To learn more about islet cell transplantation, visit the National Institute of Diabetes and Digestive and Kidney Diseases.



SOURCES: Lisa Gorn, D.O., endocrinology fellow, University of Miami Miller School of Medicine, Fla.; Joel Zonszein, M.D., director, clinical diabetes center, Montefiore Medical Center, and professor of clinical medicine, Albert Einstein College of Medicine, New York City; May 16, 2008, presentation, American Association of Clinical Endocrinologists' annual meeting, Orlando, Fla.


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. Studies test new approaches to islet transplantation
2. Living donors may be best source of insulin-producing islets for diabetes treatment
3. The new source of islet cells
4. Hidden heart condition increases the risk of death in patients waiting for kidney transplants
5. New Technology Promises Safer Organ Transplants and Soft Tissue Surgeries
6. Lung transplants in cystic fibrosis patients with life-threatening bacteria sparks debate at ISHLT
7. Parkinsons Disrupts Stem Cell Therapy Transplants
8. Lung transplants not dangerous for children with cystic fibrosis, after all
9. Study shows lifetime effects of pediatric liver transplants
10. ABC and NMDP Partner to Meet Growing Need for Stem Cell and Cord Blood Transplants, Assure Funding for Cord Blood Network, Encourage Minority Donor Recruitment
11. New technique improves outcome for living donor liver transplants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)... Output of New Molecular Entities Drops to Histori... Competition from Generics Companies, LONDON, Jul...omson,Reuters today announced the availability of ...eutical R&D Factbook, an indispensable reference,a...harmaceutical R&D,corporate finance, business str...
(Date:7/23/2008)... WINSTON-SALEM, N.C. A study out of Wake Forest ...rgency room doctors are correctly identifying pati...ratory tests haven,t yet confirmed it. , The stu...nalyzed patients with heart attack symptoms who we...t participating U.S. centers. , The findings we...
(Date:7/23/2008)... NASDAQ: CRME, TSX: COM, VANCOUVER, July 23 /...DAQ: CRME/TSX: COM) today announced that it has en...nts, LLC, an investment fund managed by,CR Intrins...Advisors, LLC,to purchase Series A convertible pre... Proceeds of the financing will be used for genera...
(Date:7/23/2008)... HOUSTON, July 23 /PRNewswire-FirstCall/ -- The... property and casualty company, today announced it...urricane Dolly, which is,sweeping through southern...-bin/prnh/20051031/NEM023LOGO ), "We are deeply ...y,s,path," said Robin A. Nicks, president of The H...
Breaking Medicine News(10 mins):Health News:Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online 2Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:The Hanover Ready to Serve Policyholders Impacted by Hurricane Dolly 2
...d at gauging adolescent health, has said that thos...riage, show a propensity to cover //the truth abou...so rigid about maintaining their virginity. The s...l encounters among students between seventh to twe...
...r Dr Kebede Worku has said that there has been a s...in the country. The prevalence rate is 5 percent//...due to their low socio-economic status in Ethiopia... he said. 'The national surveillance report estima...
...below 65 years, a government job in Assam is assur...t the appointment letter on the spot//. But there ... rural areas. 'Anybody with a medical degree can ...ew on Wednesday and Thursday and get a job. We hav...
... in the June issue of the journal Obstetrics & Gyn...at engaging in sexual intercourse during the final...very//. The study conducted by the Ohio state Uni... belief and states that just the opposite was true...
Other Medicine News:Health News:Assam Recruits Doctors to Serve in Rural Areas 2Health News:A New Study Discredits The Myth Of Sexual Intercourse Late In Pregnancy Speeds Labour & Delivery 2
(Date:7/22/2008)...nt Plan Completed Successfully, DUBLIN, Ireland, ...on,plc (NASDAQ: AMRN ) today announced that the C...d and Drug Administration (FDA) to discuss the,Com...f,hypertriglyceridemia. Following these discussion...1 in hypertriglyceridemia., Dr. Declan Doogan, He...
(Date:7/22/2008)...2 /- Hyperion,Therapeutics, Inc. toda...nt,in its Phase 1/2 clinical trial to evaluate the...ts of HPN-100 (formally called GT4P) versus,BUPHEN...a cycle disorders,(UCD). The company plans to anno...s year., (Logo: http://www.newscom.com/cgi-bin/p...
(Date:7/22/2008)...etic Risk Based on Clinical Data, Preventive Me...s, WALTHAM, Mass., July 22 /PRNewswire-FirstCall/...y announced the launch of an enhanced test report,...eart Health Genetic Test.,The test is currently ma...h,Genetic Test by Quixtar/Amway. The new report wi...
(Date:7/21/2008)... SEAS (Simvastatin and Ezetimibe in,Aortic Stenosi...,cholesterol lowering with the combination of simv...in patients with aortic stenosis., Aortic stenosi...alve in,the heart) is a relatively common disease ...treated, it can progress to death from heart failu...
Breaking Medicine Technology:Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4Popular Florida Restaurant Leads Hospitality Industry by Converting to Pasteurized Shell Eggs Usage 11283 1Popular Florida Restaurant Leads Hospitality Industry by Converting to Pasteurized Shell Eggs Usage 11283 2EBRI Policy Forum 3A Large Employers Continue to Offer Health Benefits 11281 1EBRI Policy Forum 3A Large Employers Continue to Offer Health Benefits 11281 2Elderly more likely to deny smoking when asked says Case Western Reserve University researcher 11277 1Elderly more likely to deny smoking when asked says Case Western Reserve University researcher 11277 2Shengtai Pharmaceutical Inc to Present at Roth Conference 11273 1Shengtai Pharmaceutical Inc to Present at Roth Conference 11273 2Shengtai Pharmaceutical Inc to Present at Roth Conference 11273 3
...ILEA, Hawaii and SUNNYVALE, Calif., June 27, 2007,...y announced,preliminary results from two open-labe... the potential use of Xcytrin(R),(motexafin gadoli...ate, in combination with Alimta(R) (pemetrexed) an... second-line treatment,for patients with non-small...
...S, the Netherlands, June 27, 2007-Organon, the hum...ed today that two,out of three Phase III clinical ...w long-acting fertility hormone, have reached,thei...s a new recombinant fertility hormone. It is,the f...follicular,stimulant or SFS) of which, due to its ...
Other Medicine Technology:Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 2Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 3Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 4Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 5Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 2Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 3
Electrical I/A unit for planned ECCE with peristaltic pump with linear aspiration (foot control). Independent irrigation, suction, reflux possible with multi-function footswitch that allows the surge
Globe Fixation Ring
To enter, dissect, elevate and smooth the flap. Combined features of Spatula, Dissector and Forceps. - Also available in Titanium
The CGAL gonioscopic contact glass was designed by Roussel and Fankhauser for,laser treatments of the chamber angle. It reduces the laser spot by a factor of 1.5 as compared to a Goldmann Glass.
Medicine Products: